UPDATE: Wedbush Raises Aetna's PT

According to a research report published earlier today, Wedbush has increased Aetna's

PT from $48 to $54. In the report, Wedbush commented, “Maintaining our $5.03 estimate, which includes a modest 22K, or 5% decrease in Medicare Advantage enrollment, per CMS March data; this did not materially impact EPS. We increase our price target to $54 from $48 as there has been a shift from investor concern to positive sentiment on the Supreme Court now that the hearings are over.” Wedbush maintains its Neutral rating on Aetna, which closed Friday at $49.64.